Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Pennsylvania Business Bulletin.
Press releases published on April 24, 2025
Independent Bank Corporation Reports 2025 First Quarter Results
GlobeNewswire
·
April 24, 2025
First Quarter Highlights Highlights for the first quarter of 2025 include: Increase in net interest income of $0.8 million (or 1.9% ) over the fourth quarter of 2024; Increase in tangible book value per share of $2.43 (13.2%) from March 31, 2024; Net …
NephroDI Therapeutics’ Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology
GlobeNewswire
·
April 24, 2025
April 25, 2025, Seattle, WA – NephroDI Therapeutics (NephroDI), a pharmaceutical company focusing on kidney disorders, announces that its Founder and CMO, Jeff M. Sands, M.D., is the recipient of the 2025 Robert W. Berliner Award for Excellence in Renal …
Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025
GlobeNewswire
·
April 24, 2025
– Expands Development Portfolio with Introduction of a Novel Program Targeting PSC – – Confirms Highly Specific Allosteric ACLY Inhibitor Shown to Reduce Liver Injury, Inflammation and Fibrosis Across Multiple PSC-Relevant Pre-Clinical Models – – …
ClearScale Signs New Strategic Collaboration Agreement with AWS to Empower Small and Medium-Sized Businesses to Accelerate Value in the Cloud
GlobeNewswire
·
April 24, 2025
SAN FRANCISCO, April 24, 2025 (GLOBE NEWSWIRE) -- ClearScale, an AWS Premier Tier Services Partner and cloud consulting company, announced today it has signed a multi-year strategic collaboration agreement (SCA) with Amazon Web Services (AWS) as part of …
BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 24, 2025
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …
Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025
GlobeNewswire
·
April 24, 2025
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its first …
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
GlobeNewswire
·
April 24, 2025
Norovirus GII.17 variants have overtaken GII.4 as the most prevalent strain and significantly increased norovirus outbreaks in the U.S. and European countries in 2024-2025 Cocrystal Pharma’s pan-viral protease inhibitor CDI-988 shows superior broad- …
Brera Holdings Portfolio Club Juve Stabia “The Second Team of Naples” Achieves Highest Market Value Increase in Serie B
GlobeNewswire
·
April 24, 2025
Juve Stabia’s squad value has risen 36.9%, from €11.78M to €16.13M, as the team climbs to 5th in Serie B Dublin, Ireland and Milan, Italy, April 24, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland- …
Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Technologies
GlobeNewswire
·
April 24, 2025
Presentations will be delivered by experts from a wide variety of leading research groups including Pfizer, GSK, and Bio-Techne, along with co-hosts IPA, ACROBiosystems, and Curia. SALT LAKE CITY, April 24, 2025 (GLOBE NEWSWIRE) -- Carterra Inc., the world …
CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025
GlobeNewswire
·
April 24, 2025
IRVINE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer …
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 24, 2025
STOUGHTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report first quarter 2025 financial results after the market closes on Thursday, May 8, 2025. Following the release of the …
Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025
GlobeNewswire
·
April 24, 2025
TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. Cronos’ senior management team will …
Performance Unlocked: AdOmni and LiveRamp Bring New Targeting and Attribution to CTV, OLV, and DOOH
GlobeNewswire
·
April 24, 2025
LAS VEGAS and SAN FRANCISCO, April 24, 2025 (GLOBE NEWSWIRE) -- Marketers have long struggled to measure the business impact of CTV, OLV, and DOOH—keeping these high-reach channels siloed from performance strategies. Today, AdOmni, the AI-powered video- …
NevGold Discovers More Significant Oxide Gold-Antimony Results: 2.11 g/t AuEq Over 67.1 Meters (1.30 g/t Au And 0.18% Antimony), Including 4.29 g/t AuEq Over 30.5 Meters (2.79 g/t Au And 0.33% Antimony), and Also Including 7.12 g/t AuEq Over 16.8…
GlobeNewswire
·
April 24, 2025
Vancouver, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant oxide gold-antimony (“Antimony”, “Sb”) …
Krystal Biotech to Present at Upcoming Scientific Conferences
GlobeNewswire
·
April 24, 2025
PITTSBURGH, April 24, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the Company will be presenting on multiple programs in the lung, eye, and skin at upcoming scientific conferences being held in May and …
Crbon Labs and U.S. Venture Generate and Market Credits from Canadian Orphaned Gas Well
GlobeNewswire
·
April 24, 2025
Appleton, Wis., April 24, 2025 (GLOBE NEWSWIRE) -- U.S. Venture, Inc., whose vision is to be the very best provider of transportation products, sustainability solutions, and insight driving the world forward, has reached an agreement to be Crbon Labs Inc.’ …
Amid rising global supply chain risks, Sphera study highlights urgent need for enhanced N-Tier supply chain transparency
GlobeNewswire
·
April 24, 2025
Chicago, IL, April 24, 2025 (GLOBE NEWSWIRE) -- In an era marked by escalating geopolitical tensions, evolving regulatory demands and persistent supply chain disruptions, a new study by Sphera, a leading provider of integrated sustainability, operational …
MISTRAS Group Launches MISTRAS Data Solutions Brand, Integrating Data-driven Capabilities for Customers Worldwide
GlobeNewswire
·
April 24, 2025
PRINCETON JUNCTION, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE: MG), the leading global provider of integrated, technology-enabled asset protection solutions, today announced the launch of MISTRAS Data Solutions, a unified brand …
Coda Octopus Group Reports $1.4m Engineering Services Order
GlobeNewswire
·
April 24, 2025
ORLANDO, FL, April 24, 2025 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA), a global market leader in 4D/5D/6D imaging sonar technology and new generation diving technology (DAVD) for real time subsea intelligence, …
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
GlobeNewswire
·
April 24, 2025
CAMBRIDGE, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …